AvenuesAI Limited (CCAVENUE) stock breaks out, moving up 5% intraday to ₹18.31, clearing its 6M resistance trendline.
Coforge Limited (NSE: COFORGE) is up 5% intraday at ₹1441.8, bouncing back despite a breakdown trendline status. This move occurs near the 50-DMA at ₹1366.2.
Glenmark Pharmaceuticals Limited (GLENMARK) advances its multi-country Phase 3 clinical trial for Trastuzumab rezetecan in platinum-resistant ovarian cancer.
Tata Motors Passenger Vehicles Limited (TMPV) reports a 46% sales increase in Q1 FY27, with EV sales soaring 112% year-on-year.
RITES Limited (RITES) stock cleared its 6M resistance trendline, gaining 10% intraday to ₹226.63. This breakout is backed by its partnership with Concor for.
Brainbees Solutions Limited (NSE: FIRSTCRY) rises 5% intraday to ₹235.9, despite a breakdown trendline status.
Vodafone Idea Limited (IDEA) reports strategic growth and revenue surge in Q4 FY26, driven by subscriber addition and revenue expansion.
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) drops 6% intraday to ₹299.0, breaking below crucial support in the Specialty Chemicals sector.
Ceigall India Limited (NSE: CEIGALL) advances India's clean energy vision with a 220 MW solar-BESS PPA in Madhya Pradesh.
Shilpa Medicare Limited (NSE: SHILPAMED) announces expanded partnership with Orion Corporation for developing and supplying nivolumab biosimilar in Europe.